FindTrial
Sign In

Time-Dependent Effects of clopidogrel on percutaneous coronary intervention

Time-Dependent Effects of clopidogrel on percutaneous coronary intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009918
Enrollment
Unknown
Registered
2016-11-18
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Early in the morning medication group:Early in the morning to take clopidogrel
night medication group:night to take clopidogrel

Sponsors

Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: coronary intervention during postoperative patients(aged 30-80 years; from 2016.12-2017.12)

Exclusion criteria

Exclusion criteria: 1. Severe liver and kidney function damage; 2. Severe thrombocytopenia and leukopenia, coagulant function abnormality; 3. With tumor diseases.

Design outcomes

Primary

MeasureTime frame
Platelet inhibition ratio;The rate of restenosis after coronary angiography;UCG;Holter;—

Secondary

MeasureTime frame
name;sex;age;BMI;abdominal girth;smoking history;family history;liver function;renal function;coagulogram;blood routine examination;ESR;urine routines;—

Countries

China

Contacts

Public ContactZeng Chunyu

Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing

chunyuzeng01@163.com+86 023-68757801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026